Micro-cantilever Platform for 3D Cardiac Microtissue Contraction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating microtissues, particularly for cardiac applications, face challenges due to the use of two-dimensional culture substrates that fail to replicate the biomechanical cues and three-dimensional architecture of the human myocardium, leading to compromised clinical relevance and effectiveness in pharmacological research.

Innovation Solution

A micro-fabricated platform with micro-wells surrounded by ridges and micro-cantilevers is used to cultivate cells, allowing them to form three-dimensional microtissues that can contract and be anchored by the cantilevers, enabling the measurement of contractile functions and structural characterization of the microtissues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If traditional 2D culture substrates are used, then ease of operation is improved, but manufacturing precision and biological relevance deteriorate

Engineering Contradiction:
Improveease of cell culture operationVSAvoidtissue architecture precision
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent transitions from traditional two-dimensional planar substrates to three-dimensional micro-well structures with micro-cantilevers, enabling cells to form 3D microtissues that better replicate in vivo tissue architecture and biomechanical cues while maintaining ease of operation through standardized microfabricated platforms

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Manufacturing precision

If rigid planar substrates are used, then manufacturing precision is improved, but reliability of physiological response deteriorates

Engineering Contradiction:
Improvesubstrate geometry precisionVSAvoidphysiological response reliability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent changes the mechanical parameters of the substrate by introducing flexible micro-cantilevers that can deflect in response to cellular contractile forces, transforming the substrate from a rigid static platform to a dynamic responsive platform that provides reliable physiological feedback while maintaining precise geometric control through microfabrication

Inventive Principle:
Principle #35Parameter changes

3Reliability

If 3D microtissue structures are implemented, then reliability of physiological function is improved, but device complexity increases

Engineering Contradiction:
Improvemyocardial function reliabilityVSAvoidmicrofabricated platform complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the complex 3D microtissue formation process into controlled stages using modular microfabricated components: micro-wells for cell confinement, micro-cantilevers for mechanical sensing, and standardized protocols for cell seeding and maturation, thereby achieving reliable physiological function while managing device complexity through modular design

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the generation of clinically relevant microtissues that accurately mimic human myocardial function, enabling high-throughput monitoring of maturation, structure, and function, and the assessment of pharmacological compounds and environmental factors on cardiac microtissues.

Implementation Method 1

A plurality of micro-cantilevers can be coupled to a bottom surface of the micro-well... The micro-cantilevers can anchor the contracting matrix, and can constrain the contraction of the matrix

Methodology Applied
Scientific EffectElasticity: Elasticity

Implementation Method 2

the cells can be cultivate over time to spontaneously compact the matrix

Methodology Applied
Scientific EffectCell contraction: Mechanical Force

Data Source

PatentUS9512396B2In vitro microphysiological system for high throughput 3D tissue organization and biological function
Publication Date: 2016.12.06 THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
  • US9512396B2 patent drawing
  • US9512396B2 patent drawing
  • US9512396B2 patent drawing

AI summary

Techniques for generating microtissues, including a micro-fabricated platform including at least one micro-well including a plurality of micro-cantilevers coupled thereto and surrounded by a plurality of ridges, each micro-cantilever including a cap at a terminal end thereof. The platform can be immersed in a suspension of cells. The suspension of cells can be driven into at least one micro-well, and the ridges can be de-wetted to remove excess suspension and isolate the suspension of cells in each micro-well. The cells can be driven in the suspension of each micro-well toward a top surface of the suspension, which can be polymerized to form a matrix. The cells can be cultivated to spontaneously compact the matrix such that the micro-cantilevers anchor and constrain the contracting matrix to form a band of microtissue that spans across the micro-cantilevers.